Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2150 to 2199 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1075\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 1 (ec 2.7.7.41) (cdp-diglyceride synthetase 1) (cdp-diglyceride pyrophosphorylase 1) (cdp- diacylglycerol synthase 1) (cds 1) (ctp:phosphatidate cytidylyltransferase 1) (cdp-dag synthase 1) (cdp-dg synthetase 1). [source:swissprot;acc:q92903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6441.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7034.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09211\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1076\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
katanin p80 subunit b 1; katanin (80 kda); katanin p80 (wd40-containing) subunit b 1. [source:refseq;acc:nm\_005886]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7992.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8290.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03733\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09202\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1077\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l8. [source:swissprot;acc:p25120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8157.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8461.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03732\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09202\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1078\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycyl-trna synthetase (ec 6.1.1.14) (glycine--trna ligase) (glyrs). [source:swissprot;acc:p41250]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7948.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8245.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03731\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7032.19\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09202\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1079\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6439.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7032.22\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thromboxane-a synthase (ec 5.3.99.5) (txa synthase) (txs). [source:swissprot;acc:p24557]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8008.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8307\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0373\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1080\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related protein rab-18. [source:swissprot;acc:q9np72]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8237.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8545.01\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03729\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 2. [source:swissprot;acc:o15127]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7031.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.092\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1081\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec15b. [source:swissprot;acc:q9y2d4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8149.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8453.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03728\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 3. [source:swissprot;acc:o14828]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7031.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.092\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1082\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lymphoid enhancer binding factor 1 (lef-1) (t cell-specific transcription factor 1-alpha) (tcf1-alpha). [source:swissprot;acc:q9uju2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7502.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7782.47\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03728\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 1. [source:swissprot;acc:o15126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6439.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7031.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.092\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1083\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l18a. [source:swissprot;acc:q02543]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7735.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8024.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03727\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec15b. [source:swissprot;acc:q9y2d4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6213.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6785.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09198\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1084\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase mlrq subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-mlrq) (ci-mlrq). [source:swissprot;acc:o00483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7936.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8232.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03726\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 2 (ec 2.7.7.41) (cdp-diglyceride synthetase 2) (cdp-diglyceride pyrophosphorylase 2) (cdp- diacylglycerol synthase 2) (cds 2) (ctp:phosphatidate cytidylyltransferase 2) (cdp-dag synthase 2) (cdp-dg synthetase 2). [source:swissprot;acc:o95674]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6437.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7029.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09192\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1085\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycerol-3-phosphate transporter (g-3-p transporter) (g-3-p permease). [source:swissprot;acc:p57057]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6520.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7119.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09187\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh:ubiquinone oxidoreductase mlrq subunit homolog (nuoms). [source:swissprot;acc:q9nrx3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7936.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8232.26\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03726\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1086\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proline oxidase, mitochondrial precursor (ec 1.5.3.-) (proline dehydrogenase). [source:swissprot;acc:o43272]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6520.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7119.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09187\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1087\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cad protein [includes: glutamine-dependent carbamoyl-phosphate synthase (ec 6.3.5.5); aspartate carbamoyltransferase (ec 2.1.3.2); dihydroorotase (ec 3.5.2.3)]. [source:swissprot;acc:p27708]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8173.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8477.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03725\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
junction plakoglobin (desmoplakin iii). [source:swissprot;acc:p14923]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5732.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6256.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.09139\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1088\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tax interaction protein 1. [source:refseq;acc:nm\_014604]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin interacting protein; upregulated by 1,25-dihydroxyvitamin d-3. [source:refseq;acc:nm\_006472]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8012.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8310.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03723\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1089\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
metaxin 1. [source:swissprot;acc:q13505]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8387.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8699.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03722\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine--pyruvate aminotransferase (ec 2.6.1.51) (spt) (alanine-- glyoxylate aminotransferase) (ec 2.6.1.44) (agt). [source:swissprot;acc:p21549]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6390.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6973.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0912\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1090\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
catenin (cadherin-associated protein), alpha-like 1; alpha-catulin. [source:refseq;acc:nm\_003798]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8271.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8579.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03722\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5651.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6164.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09086\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1091\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 2 (vamp-2) (synaptobrevin 2). [source:swissprot;acc:p19065]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03718\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1092\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hskin17 protein. [source:refseq;acc:nm\_012311]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicule-associated membrane protein 4 (vamp-4). [source:swissprot;acc:o75379]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03718\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1093\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8276.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8584.41\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03717\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1094\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 1 (vamp-1) (synaptobrevin 1). [source:swissprot;acc:p23763]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.38\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.03717\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1095\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nit protein 2. [source:refseq;acc:nm\_020202]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8056.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.41\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1096\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj470l14.3 (novel protein similar to the arp2/3 protein complex subunit p21-arc (arc21)). [source:sptrembl;acc:q9h5b6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7832.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8123.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03716\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin protein. [source:refseq;acc:nm\_032559]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5356.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5842.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.09072\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1097\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homolog of yeast maf1. [source:refseq;acc:nm\_032272]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-associated membrane protein 3 (vamp-3) (synaptobrevin 3) (cellubrevin) (ceb). [source:swissprot;acc:q15836]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8056.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8356.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03716\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1098\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lamin b receptor (integral nuclear envelope inner membrane protein) (lmn2r). [source:swissprot;acc:q14739]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7997.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8294.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03715\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 2. [source:refseq;acc:nm\_178865]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1099\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nardilysin precursor (ec 3.4.24.61) (n-arginine dibasic convertase) (nrd convertase) (nrd-c). [source:swissprot;acc:o43847]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7832.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8123.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03715\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 1 (transmembrane protein sbbi99). [source:swissprot;acc:q13530]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed 1 protein like. [source:swissprot;acc:q9nrx5]\vspace{3pt}}&&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/